Patents by Inventor Ira Gantz

Ira Gantz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Melanocortin receptor polypeptides MC-3, MC-4, and MC-5
    Patent number: 6117975
    Abstract: Genes encoding melanocortin receptors have been identified, isolated, cloned and localized to their chromosomal positions. These genes have been used to transfect mammalian cells lacking endogenous melanocortin receptors to induce expression. Additionally, melanocortin receptor binding, secondary signalling, and tissue distribution has been characterized. The genes and their gene products may therefore be used to to provide therapeutic vehicles for the treatment of processes involving the function of melanocortin receptors.
    Type: Grant
    Filed: July 23, 1996
    Date of Patent: September 12, 2000
    Assignee: The Regents of the University of Michigan
    Inventors: Tadataka Yamada, Ira Gantz
  • Recombinant genomic clone encoding the histamine H2 receptor, methods for production thereof, and protein produced therefrom
    Patent number: 5885824
    Abstract: Recombinant genomic clones encoding histamine H1, H2 and H3 receptors, recombinant H1, H2 and H3 receptors, and methods for obtaining these.
    Type: Grant
    Filed: September 9, 1993
    Date of Patent: March 23, 1999
    Assignee: The Regents of the University of Michigan
    Inventors: Tadataka Yamada, Ira Gantz
  • Probes and methods for detecting melanocortin-4 receptor
    Patent number: 5869257
    Abstract: Genes encoding melanocortin receptors have been identified, isolated, cloned and localized to their chromosomal positions. These genes have been used to transfect mammalian cells lacking endogenous melanocortin receptors to induce expression. Additionally, melanocortin receptor binding, secondary signalling, and tissue distribution has been characterized. The genes and their gene products may therefore be used to provide therapeutic vehicles for the treatment of processes involving the function of melanocortin receptors.
    Type: Grant
    Filed: April 23, 1997
    Date of Patent: February 9, 1999
    Assignee: The Regents Of The University of Michigan
    Inventors: Tadataka Yamada, Ira Gantz
  • Probes and methods for detecting melanocortin-5 receptor
    Patent number: 5817787
    Abstract: Genes encoding melanocortin receptors have been identified, isolated, cloned and localized to their chromosomal positions. These genes have been used to transfect mammalian cells lacking endogenous melanocortin receptors to induce expression. Additionally, melanocortin receptor binding, secondary signalling, and tissue distribution has been characterized. The genes and their gene products may therefore be used to to provide therapeutic vehicles for the treatment of processes involving the function of melanocortin receptors.
    Type: Grant
    Filed: April 23, 1997
    Date of Patent: October 6, 1998
    Assignee: The Regents Of The University Of Michigan
    Inventors: Tadataka Yamada, Ira Gantz
  • Gene encoding melanocortin-5 receptor and methods of use
    Patent number: 5710265
    Abstract: Genes encoding melanocortin receptors have been identified, isolated, cloned and localized to their chromosomal positions. These genes have been used to transfect mammalian cells lacking endogenous melanocortin receptors to induce expression. Additionally, melanocortin receptor binding, secondary signalling, and tissue distribution has been characterized. The genes and their gene products may therefore be used to to provide therapeutic vehicles for the treatment of processes involving the function of melanocortin receptors.
    Type: Grant
    Filed: June 27, 1996
    Date of Patent: January 20, 1998
    Assignee: The Regents Of The University Of Michigan
    Inventors: Tadataka Yamada, Ira Gantz
  • Genes encoding melanocertin-4 receptor and methods of use
    Patent number: 5703220
    Abstract: Genes encoding melanocortin receptors have been identified, isolated, cloned and localized to their chromosomal positions. These genes have been used to transfect mammalian cells lacking endogenous melanocortin receptors to induce expression. Additionally, melanocortin receptor binding, secondary signalling, and tissue distribution has been characterized. The genes and their gene products may therefore be used to provide therapeutic vehicles for the treatment of processes involving the function of melanocortin receptors.
    Type: Grant
    Filed: June 27, 1996
    Date of Patent: December 30, 1997
    Assignee: The Regents Of The University Of Michigan
    Inventors: Tadataka Yamada, Ira Gantz
  • Genes encoding melanocortin receptors
    Patent number: 5622860
    Abstract: Genes encoding melanocortin receptors have been identified, isolated, cloned and localized to their chromosomal positions. These genes have been used to transfect mammalian cells lacking endogenous melanocortin receptors to induce expression. Additionally, melanocortin receptor binding, secondary signalling, and tissue distribution has been characterized. The genes and their gene products may therefore be used to to provide therapeutic vehicles for the treatment of processes involving the function of melanocortin receptors.
    Type: Grant
    Filed: February 17, 1994
    Date of Patent: April 22, 1997
    Assignee: The Regents Of The University Of Michigan
    Inventors: Tadataka Yamada, Ira Gantz